Bacteria-Based Therapeutic Agents Designed to Modulate the Body’s Immune System Towards Antigen-Specific Immune Tolerance
Time: 11:30 am
day: Conference Day Two
Details:
- Introducing the bacteria-based therapeutics platform for delivery of biologics directly to the gut
- Showcasing its potential to modulate the body's immune system towards antigen-specific immune tolerance
- Highlighting the phase 1b/2a study results in recent-onset Type 1 Diabetes
